Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Drugs for Short Bowel Syndrome Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2018-2033)
2.2 Drugs for Short Bowel Syndrome Growth Trends by Region
2.2.1 Global Drugs for Short Bowel Syndrome Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drugs for Short Bowel Syndrome Historic Market Size by Region (2018-2023)
2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2024-2033)
2.3 Drugs for Short Bowel Syndrome Market Dynamics
2.3.1 Drugs for Short Bowel Syndrome Industry Trends
2.3.2 Drugs for Short Bowel Syndrome Market Drivers
2.3.3 Drugs for Short Bowel Syndrome Market Challenges
2.3.4 Drugs for Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2018-2023)
3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2022
3.5 Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Short Bowel Syndrome Breakdown Data by Type
4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2018-2023)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2024-2033)
5 Drugs for Short Bowel Syndrome Breakdown Data by Application
5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2018-2023)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drugs for Short Bowel Syndrome Market Size (2018-2033)
6.2 North America Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Drugs for Short Bowel Syndrome Market Size by Country (2018-2023)
6.4 North America Drugs for Short Bowel Syndrome Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Short Bowel Syndrome Market Size (2018-2033)
7.2 Europe Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Drugs for Short Bowel Syndrome Market Size by Country (2018-2023)
7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size (2018-2033)
8.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2018-2023)
8.4 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Short Bowel Syndrome Market Size (2018-2033)
9.2 Latin America Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2018-2023)
9.4 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size (2018-2033)
10.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2018-2023)
10.4 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ardelyx
11.1.1 Ardelyx Company Detail
11.1.2 Ardelyx Business Overview
11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.1.5 Ardelyx Recent Development
11.2 Emmaus Life Sciences
11.2.1 Emmaus Life Sciences Company Detail
11.2.2 Emmaus Life Sciences Business Overview
11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.2.5 Emmaus Life Sciences Recent Development
11.3 GLyPharma Therapeutic
11.3.1 GLyPharma Therapeutic Company Detail
11.3.2 GLyPharma Therapeutic Business Overview
11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.3.5 GLyPharma Therapeutic Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Detail
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Detail
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Detail
11.7.2 OxThera Business Overview
11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.7.5 OxThera Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Detail
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.8.5 Sancilio & Company Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.9.5 Takeda Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Detail
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2018-2023)
11.10.5 Zealand Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Other
Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Drugs for Short Bowel Syndrome Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Drugs for Short Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Drugs for Short Bowel Syndrome Market Share by Region (2018-2023)
Table 10. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Drugs for Short Bowel Syndrome Market Share by Region (2024-2033)
Table 12. Drugs for Short Bowel Syndrome Market Trends
Table 13. Drugs for Short Bowel Syndrome Market Drivers
Table 14. Drugs for Short Bowel Syndrome Market Challenges
Table 15. Drugs for Short Bowel Syndrome Market Restraints
Table 16. Global Drugs for Short Bowel Syndrome Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Drugs for Short Bowel Syndrome Market Share by Players (2018-2023)
Table 18. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2022)
Table 19. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Drugs for Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Short Bowel Syndrome Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2018-2023)
Table 27. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2024-2033)
Table 29. Global Drugs for Short Bowel Syndrome Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2018-2023)
Table 31. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2024-2033)
Table 33. North America Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Drugs for Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Drugs for Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Drugs for Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Drugs for Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Drugs for Short Bowel Syndrome Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Drugs for Short Bowel Syndrome Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2024-2033) & (US$ Million)
Table 48. Ardelyx Company Detail
Table 49. Ardelyx Business Overview
Table 50. Ardelyx Drugs for Short Bowel Syndrome Product
Table 51. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 52. Ardelyx Recent Development
Table 53. Emmaus Life Sciences Company Detail
Table 54. Emmaus Life Sciences Business Overview
Table 55. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product
Table 56. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 57. Emmaus Life Sciences Recent Development
Table 58. GLyPharma Therapeutic Company Detail
Table 59. GLyPharma Therapeutic Business Overview
Table 60. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product
Table 61. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 62. GLyPharma Therapeutic Recent Development
Table 63. Merck Company Detail
Table 64. Merck Business Overview
Table 65. Merck Drugs for Short Bowel Syndrome Product
Table 66. Merck Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Naia Pharmaceuticals Company Detail
Table 69. Naia Pharmaceuticals Business Overview
Table 70. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product
Table 71. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 72. Naia Pharmaceuticals Recent Development
Table 73. Nutrinia Company Detail
Table 74. Nutrinia Business Overview
Table 75. Nutrinia Drugs for Short Bowel Syndrome Product
Table 76. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 77. Nutrinia Recent Development
Table 78. OxThera Company Detail
Table 79. OxThera Business Overview
Table 80. OxThera Drugs for Short Bowel Syndrome Product
Table 81. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 82. OxThera Recent Development
Table 83. Sancilio & Company Company Detail
Table 84. Sancilio & Company Business Overview
Table 85. Sancilio & Company Drugs for Short Bowel Syndrome Product
Table 86. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 87. Sancilio & Company Recent Development
Table 88. Takeda Company Detail
Table 89. Takeda Business Overview
Table 90. Takeda Drugs for Short Bowel Syndrome Product
Table 91. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 92. Takeda Recent Development
Table 93. Zealand Pharma Company Detail
Table 94. Zealand Pharma Business Overview
Table 95. Zealand Pharma Drugs for Short Bowel Syndrome Product
Table 96. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2018-2023) & (US$ Million)
Table 97. Zealand Pharma Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Short Bowel Syndrome Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Drugs for Short Bowel Syndrome Market Share by Type: 2022 VS 2033
Figure 3. GLP-2 Features
Figure 4. Growth Hormone Features
Figure 5. Glutamine Features
Figure 6. Other Features
Figure 7. Global Drugs for Short Bowel Syndrome Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Drugs for Short Bowel Syndrome Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Drugs for Short Bowel Syndrome Report Years Considered
Figure 13. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Drugs for Short Bowel Syndrome Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Drugs for Short Bowel Syndrome Market Share by Region: 2022 VS 2033
Figure 16. Global Drugs for Short Bowel Syndrome Market Share by Players in 2022
Figure 17. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2022
Figure 19. North America Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Drugs for Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 21. United States Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Drugs for Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 25. Germany Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Region (2018-2033)
Figure 33. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Drugs for Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 41. Mexico Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Country (2018-2033)
Figure 45. Turkey Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Drugs for Short Bowel Syndrome Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 48. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 49. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 51. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 52. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 53. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 54. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 55. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 56. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed